“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
(Visited 34 times, 1 visits today)
Related posts:
Turkish gold exports rise 800 pct on demand from Iran
Deported veterans' group ignores Border Patrol, repaints border wall mural
Report: Obama officials issued $216 billion in regulations last year
Police, Looking for 6 Foot 270 lb Black Man, Shoot 2 Asian Women Delivering Newspapers
German Chancellor Angela Merkel says no country will have to leave eurozone
Iran’s foreign minister condemns Holocaust on Facebook
Tax-free zones created around 8 NY colleges under Start-Up NY
Iowa Farms Minting Millionaires as Rich-Poor Gap Widens
IMF to Germany: “Fiscal over-performance should be firmly avoided"
New world record as two bottles of Macallan whisky fetch US$2.11 million
Unhappy about new limits, gun makers urged to move to New Hampshire
Sen. Jay Rockefeller pitches cybersecurity bill to top CEOs
IRS Begins Assessing Back Taxes On Tech Company-Provided Meals
Bursting Switzerland’s bubble
Crisis Hits German Luxury Carmakers